BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference
BioMarin Pharmaceutical announced participation in the BofA Securities 2020 Napa Biopharma Conference on June 24, 2020, at 11:30 AM ET. Key representatives, Henry Fuchs, M.D., President of Worldwide Research & Development, and Brian Mueller, Acting CFO, will present. The event will feature a live audio webcast accessible via the company's investor site. BioMarin focuses on innovative therapies for serious rare disorders, with six commercialized products and numerous candidates in development.
- None.
- None.
SAN RAFAEL, Calif., June 23, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Henry Fuchs, M.D., President, Worldwide Research & Development and Brian Mueller, Acting Chief Financial Officer, will participate in the BofA Securities 2020 Napa Biopharma Conference on June 24, 2020 at 11:30am ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
!["BioMarin]("https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.jpg" "\"BioMarin"){kind=logo}
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: | |
Investors | Media |
Traci McCarty | Debra Charlesworth |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (415) 455-7451 |
!["Cision"]("https://c212.net/c/img/favicon.png?sn=SF41574&sd=2020-06-23" "\"Cision\"")
View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2020-napa-biopharma-conference-301080544.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When is BioMarin participating in the BofA Securities Napa Biopharma Conference?
Who will represent BioMarin at the BofA Securities Conference?
How can I access the live webcast of BioMarin's presentation?
What does BioMarin specialize in?
What is the stock symbol for BioMarin Pharmaceutical?
